Corticotropin
Acth
Sold as XS H2O Liquescence
- Drug class
- Acth
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 240
Overview
Plain-language summary, compiled from the cited regulatory records
Corticotropin is a substance belonging to the drug class ACTH [1]. It is approved for indications that provide potentized homeo-nutritional support to help reduce puffiness from excess water [1]. These claims are based on traditional homeopathic practice and have not been evaluated by regulatory bodies [1].
This active ingredient is available under various brand names, including XS H2O Liquescence [1]. In the past 12 months, there have been 240 adverse event reports associated with Corticotropin [2]. The most frequently reported reactions include fatigue, injection site bruising, headache, injection site pain, and injection site pruritus [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | October 31, 2024 |
USUnited States· FDA
1 product
Uses
† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
How to take
Drug interactions
Known interactions involving Corticotropin. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 16a266cd-79cc-4f… · revised October 31, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.